VCEL.NASDAQVericel CORP

Form 4: Vericel Corp Executive Jonathan Siegal Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Jonathan Siegal, Principal Accounting Officer of Vericel Corp, sold 545 shares of common stock on July 5, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On July 5, 2024, Jonathan Siegal, the Principal Accounting Officer of Vericel Corp, sold 545 shares of the company's common stock.
  • The sale was executed at a price of $45 per share.
  • The transaction was conducted under a Rule 10b5-1 trading plan adopted on March 13, 2024.
  • Following the transaction, Siegal directly owns 1,033 shares of Vericel Corp.
  • These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Insider trading activity is always closely watched by investors. Sales by executives can sometimes be interpreted negatively, but the use of a pre-arranged 10b5-1 trading plan suggests the transaction was planned and not based on any inside information.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders, but the use of a 10b5-1 plan mitigates concerns about insider information.

Key Dates

DateDescription
March 13, 2024Date the reporting person adopted a Rule 10b5-1 trading plan
July 05, 2024Date of the transaction (stock sale)
July 09, 2024Date of the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.